The Role Of Actin Cytoskeletal Pathology In Alzheimer's Disease

Principal Investigator
Jiaqi Yao, MD, PhD
Weill Medical College of Cornell University
New York, NY, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$100,000
Active Dates
April 01, 2009 - March 31, 2011
Grant ID
A2009606
Mentor(s)
M. Flint Beal, MD, Weill Medical College of Cornell University
Goals
To investigate mechanisms and consequences of abnormal alterations of the actin cytoskeleton, which may play critical roles in Alzheimer’s disease (AD) causes and development. The proposed project focuses on a field that is largely unknown and will help us to understand the pathological development of AD from a fresh point of view.
Summary
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive impairment. We propose to investigate the role of abnormalities in actin, a major structural protein in neurons, in the disease. Abnormal rod-like accumulations of actin can be seen in neurons in Alzheimer’s disease brains. We will examine potential mechanisms that cause these rods to form and follow consequences of their formation. This area has not previously received significant attention, and these studies should provide a fresh point of view and new therapeutic targets.
1. We will test the mechanisms inducing abnormal changes of the actin cytoskeleton.
2. We will examine the significant consequences of the actin pathology.
Progress Updates
In addition to beta-amyloid (Aβ) plaques and neurofibrillary tangles, Alzheimer’s disease (AD) brains also contain Hirano bodies—rod-shaped structures containing actin and cofilin (cell structure proteins). Actin and cofilin play critical roles in nerve function. Drs. Jiaqi Yao, Flint Beal, and colleagues found increased levels of cofilin in mice with AD, and primary neurons from these mice had cofilin-containing, rod -like structures resembling Hirano bodies. Overexpressing active cofilin protein in normal neurons was sufficient to induce formation of these rod-like structures.
Dr. Yao and colleagues found two microRNAs that repressed the creation of cofilin in mice. microRNAs are short gene products naturally found in cells of the body that “silence” or reduce gene protein expression. Of note, one of these two microRNAs is also decreased in human AD brain. Dr. Yao showed in a mouse model of AD that brain levels of these two microRNAs are decreased, with corresponding increases in brain cofilin levels, and formation of cofilin-actin rods in nerve cells and brain sections. Overexpression of inactive cofilin does not induce rod formation.
These data suggest that deficiency of these microRNAs contribute to increased expression of cofilin, leading to Alzheimer’s disease. This is the first time that abnormal cofilin protein levels have been shown in an AD mouse model. In addition, this is the first report of microRNA involvement in cofilin abnormality. In the future, gene therapy targeting to increase expression of both mRNAs might reverse the cofilin induction of rod-like structure deposits in the brain and perhaps contribute to cognitive recovery.
Grants
Related Grants
Alzheimer's Disease Research
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022
Principal Investigator
Hyunjun Yang, PhD
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022

Principal Investigator
Hyunjun Yang, PhD
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD